Verywell | What to Know About the 6 Peptides Backed by an FDA Advisory Panel
Verywell Health reports that an FDA Pharmacy Compounding Advisory Committee recommended allowing six peptides, including BPC-157, to be used in compounded medications. Rachel Frank, MD, a sports medicine specialist at UCHealth, cautioned that controlled human clinical data is limited and reported benefits are largely anecdotal.
Why UCHealth is included
Rachel Frank, MD, an orthopedic surgeon and sports medicine specialist at UCHealth, discusses the absence of controlled human evidence supporting BPC-157 for ligament or tendon healing and notes that athletes reporting improvement may also be receiving treatments such as physical therapy.
Read the full story at Verywell Health.
Related UCHealth background
Peptides: Doctors explain the benefits, risks and FDA concerns provides additional context from Rachel Frank, MD and Jack Spittler, MD about the growing interest in injectable peptides, the limited evidence supporting their use and physicians’ safety concerns.